ASPIRE PHARMA LIMITED

Company number 06828501 ·

Active

Executive summary

Aspire Pharma has built a compelling niche pharmaceutical platform combining regulatory expertise, private equity backing, and disciplined acquisition execution—evidenced by net assets growing from £17.6m to £65.8m over six years and turnover exceeding £115m in 2024. The company's strategic trajectory is sound, with EU expansion and a normalizing regulatory environment providing meaningful growth optionality, though management must address the operating profit decline and ensure the organizational capacity exists to execute on multiple fronts simultaneously. The next 18-24 months will be pivotal: if Aspire can translate its pipeline and geographic expansion into sustained profitable growth while maintaining cost discipline, it will cement its position as the leading UK-based niche pharmaceutical platform.

Read the full AI analysis →

Shareholders' funds

£87,624

Balance sheet as at 2025-12-31

View full accounts →

Overview

Company type
Private Limited Company
Incorporated
2009-02-24
Employees
114 (2025 accounts · was 100 in 2024)
Registered office
102 High Street, Godalming, Surrey, GU7 1DS
Postcode
GU7 1DS
Capital
2,600,003 GBP
Accounts category
Full
Charges
0 outstanding

Accounts

Last made up to
2025-12-31
Next due by
2027-09-30
Financial year end
31 December

Confirmation statement

Last statement dated
2026-08-22
Next due by
2027-09-05
View filing history →

Nature of business (SIC)

  • 46460 Wholesale of pharmaceutical goods

Officers 8 current · 8 resigned

Appointed 2023-04-28
Appointed 2020-06-15
INVESTMENT PROFESSIONAL Appointed 2020-06-15
Appointed 2020-06-15
Appointed 2020-06-15

View all officers and resignations →

Group structure 4 subsidiaries

Controlled by APHL 2 LIMITED — since 2019-09-19

From persons-with-significant-control filings on the public register.

Public contracts won 1

£1,351,341,890 total awarded value where published.

Contains public sector information licensed under the Open Government Licence v3.0 (Contracts Finder).

Modern slavery statement

Registered a modern slavery statement for 2025 (period to 2024-12-31) — 2 years on the registry.

Read the statement summary on the government modern slavery statement registry. Contains public sector information licensed under the Open Government Licence v3.0.

Data protection registration

Registered with the ICO as a data protection fee payer — Z1868117 (Tier 2), registered since 2009.

Information Commissioner's Office register of fee payers, licensed under the Open Government Licence.

Contact details

Website
aspirepharma.co.uk

Among its peers

The largest employer

of 20 similar companies in GU, with 114 staff. Among the oldest 25% of its local peers.

No.12 of the largest wholesale of pharmaceutical goods companies in Guildford →

Competitors Guildford

This company ranks 12 among wholesale of pharmaceutical goods in Guildford.

Full league table →

The class of 2009

21%

of the 315,096 companies incorporated in 2009 are still active today; 77% have since been dissolved.

A fact about the year, not a forecast for this company.

Survival rates for every incorporation year →

Property in England & Wales 2 titles

Leasehold
2
Most recent registration
2024-10-03
Price paid, where recorded
£135,486
Where
Leicestershire (1), Hampshire (1)
Title numberCounty Tenure RegisteredPrice paid
LT556770 Leicestershire Leasehold 2024-10-03 £135,486
SH52079 Hampshire Leasehold 2019-05-16

For addresses and the authoritative register entry, use HM Land Registry's official search (£3 per title).

Information produced by HM Land Registry. © Crown copyright 2026. Dataset as at 2026-08.